nocrarp
11-10-2022, 02:06 PM
We previously showed that the de novo expression of CD44v in metaplasia cells potentiates ROS defense in these cells, and thereby promotes the development of SPEM 17 tamoxifen citrate ([Only registered and activated users can see links]) The present study aims at determining the mechanism of cell death elicited by TD